SSRI Side Effects and Mood Changes: When to Contact Your Clinician
How to report agitation and mood changes during SSRI treatment, why medication changes need clinical guidance, and why ketamine is not automatically a safer substitute.
Share
New agitation, restlessness, or unusual mood changes during antidepressant treatment deserve prompt attention. Specific symptoms are more helpful to a clinician than a broad label such as “erratic behavior.” Do not stop or replace a prescribed antidepressant based on a frightening anecdote.
Important: Compounded ketamine is not FDA-approved. FDA has not reviewed these products for safety, effectiveness, or quality before marketing. Ketamine is not FDA-approved for psychiatric conditions. Compounded nasal spray is different from FDA-approved esketamine (Spravato), which is administered in certified healthcare settings. Read FDA's explanation of compounded drugs.
Which changes should be reported?
NIH MedlinePlus guidance for sertraline, an SSRI, advises contacting a clinician about new or worsening depression, severe restlessness, agitation, unusual excitement, sleep changes, or thoughts of self-harm. Antidepressant warnings include increased suicidal thoughts and behaviors in children, adolescents, and young adults. Monitoring matters when treatment starts and when doses change.
Tell your prescriber when a symptom started, whether the dose changed, and what other medicines or substances you use. Mention a history of unusually elevated mood, reduced need for sleep, or bipolar disorder. Timing alone cannot prove that a medication caused a behavior.
Should you stop an SSRI yourself?
Do not abruptly stop, taper, or switch medication without clinical guidance. Some antidepressants can cause discontinuation symptoms. A clinician can assess the seriousness of the problem and discuss a supervised change if needed. If you cannot keep yourself safe or are experiencing a medical emergency, call 911 or seek emergency care.
Does an SSRI problem mean ketamine is the next step?
No. A review may involve clarifying the diagnosis, changing an existing treatment, psychotherapy, or other options. Ketamine should not be presented as a way to avoid all psychiatric risks or as a proven safer replacement for an SSRI.
Research on intravenous ketamine and supervised esketamine does not establish outcomes for compounded at-home nasal spray. A consultation should address the full treatment history and compare reasonable alternatives, including their monitoring needs. Sharing accurate information about side effects helps that discussion; sensational legal cases and unverified stories do not provide an individual risk assessment.
Risks and the treatment setting
Ketamine can cause sedation, dissociation, impaired thinking or coordination, increased blood pressure, and slowed breathing. Abuse, misuse, dependence, worsening psychiatric symptoms, and urinary or bladder problems are additional concerns. A prescription or lower dose does not eliminate these risks.
At home, a healthcare professional is not onsite to monitor you or respond immediately to a serious reaction. Virtual visits and follow-up support do not provide the same monitoring as an onsite healthcare team. Discuss your medications, health history, monitoring needs, and emergency plan with your clinician.
Discuss your options
Bliss Mist Rx LLC provides telehealth services and does not compound or manufacture medications. A licensed clinician determines whether treatment is appropriate. A consultation does not guarantee a prescription. If prescribed, medication is dispensed by an independent, appropriately licensed compounding pharmacy.
Book a Free Virtual Appointment or Follow-Up.
This article is general education and does not replace individualized medical advice.
